Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Manchester-Nashua, NH MSA — September 2026
Manchester life sci pay splits: scarcity premiums rise, data roles soften.
Metro Clinical Research Associate pay has hit $130,450 against a $90,956 national median, even as Hillsborough County wages climb 6.1% and Lonza prepares to add up to 400 roles by 2027.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Hillsborough County unemployment: 2.7% — June 2026, vs 4.1% national rate
- Hillsborough avg weekly wage growth: 6.1% — Highest among large NH counties, YoY
- CRA advertised pay, metro vs national: $130,450 vs $90,956 — Metro running 43% above national median
- Lonza Portsmouth planned headcount add: 300-400 roles — By end-2027, across mfg/quality/support
Key takeaways
Clinical Research Associate pay has inverted the national pattern.
Metro median of $130,450 sits 43% above the $90,956 national figure, a reversal that suggests Manchester-area sponsors and CROs are paying a local scarcity premium rather than following national rate trends. Benchmarking this role against national data alone would understate retention risk.
Lonza's expansion is a regional wage-setting event, not just a hiring story.
Adding 300-400 roles split across manufacturing, quality, and support by 2027 gives Lonza outsized influence over local technician and quality-role pay floors. Smaller biotech and device employers nearby should expect upward pressure on entry- and mid-level manufacturing compensation regardless of their own hiring plans.
Regulatory Affairs scarcity is now visible in metro-level data.
Metro median advertised pay of $105,402 has edged past the $104,000 national figure, consistent with national reporting that experienced regulatory professionals are in short global supply. Given VP-level regulatory pay nationally reaching $320K-$580K, mid-career regulatory retention may deserve more attention than headcount expansion at the top.
Clinical Data Manager softness bucks the broader tightening narrative.
Metro median pay fell to $112,177, tracking a national decline to $123,031, even as most clinical and regulatory roles in the metro show upward pressure. This divergence may reflect automation or offshoring absorption in data management functions ahead of other specialties — worth testing before assuming uniform talent tightness across clinical operations.
Median advertised pay by role — Manchester-Nashua, NH MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $100,092 | $117,607 | $134,363 | Significant increase | $131,354 |
| Clinical Research Associate | $130,450 | $130,450 | $130,450 | Significant increase | $90,956 |
| Lab Technician * | $42,723 | $52,416 | $57,070 | Moderate increase | $47,402 |
| Regulatory Affairs Specialist | $87,255 | $105,402 | $105,402 | Significant increase | $104,000 |
| Clinical Data Manager * | $96,400 | $112,177 | $119,196 | Moderate decline | $123,031 |
| Biostatistician * | $156,421 | $156,466 | $159,623 | Moderate increase | $133,322 |
| Validation Engineer | $98,292 | $103,666 | $106,145 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Hillsborough County unemployment sits near 2.7-3.0% while average weekly wages climbed 6.1% year-over-year, reflecting a metro where healthcare and life sciences employment expansion collides with a shrinking pool of manufacturing-adjacent technical talent. Lonza's Portsmouth facility plans to add 300-400 workers by end-2027 across manufacturing, quality, and support functions, intensifying competition for exactly the technician and engineering profiles the state's own workforce economists describe as structurally undersupplied.
What it means
Metro-level Clinical Research Associate pay has pulled sharply ahead of national median ($130,450 vs $90,956), and Regulatory Affairs Specialist advertised pay now exceeds the national figure as well — both signals that Manchester-area employers are bidding aggressively for credentialed talent rather than relying on organic labor supply growth. With UNH researchers describing a 'talent alignment problem' rather than a shortage, build-vs-outsource decisions should weigh whether CDMO/CRO partnerships can absorb technician and supply-chain gaps faster than internal pipeline investment; current conditions suggest reviewing regulatory and clinical compensation bands against Lonza's anchor-tenant wage floor before losing mid-career staff to a 300-400 person hiring wave next door.
Looking ahead
Expected: Lonza's phased hiring toward 300-400 net new roles by end-2027 will likely begin showing in local job postings volume this quarter. Watch whether competing manufacturers and device makers respond with pay adjustments before losing incumbent technicians.
Emerging pressure point: Ongoing unemployment claims statewide are running 23% above the same period two years ago despite a 2.8% headline rate, suggesting friction in matching displaced workers to open life sciences roles. Technician and supply-chain openings may persist even as claims rise, reinforcing the alignment-problem thesis over a shortage narrative.
Worth watching: NH-LIFT workforce pipeline initiatives remain 18-24 months from measurable hiring impact, meaning near-term technician and engineer gaps will not be resolved through training pipelines this cycle. Build-vs-outsource calculus should assume current scarcity persists through at least 2027.
Potential inflection point: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions while 64% of surveyed organizations keep recruiting, a pattern that could release mid-career talent into regional candidate pools. Monitor whether any laid-off specialists from larger national employers surface in Manchester-area applicant flow.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.